MCK Related New Coverage
-
JMP Resumes PBM Providers: CVS, MCK, ESRX at Outperform, CTRX at Market Perform
-
ISI Group Starts McKesson (MCK) at Overweight
-
Edward Jones Starts McKesson (MCK) at Hold
-
Cowen Starts Healthcare Stocks: ESRX, MHS, MDRX, CAH, MCK, ABC at Outperform, CERN, SXCI, QSII at Neutral
-
Goldman Sachs Rates McKesson (MCK) at Buy
-
Susquehanna Initiates Coverage on McKesson Corp (MCK) with a Positive
-
Citi Assumes Coverage on Pharmacy Benefit Management & Distribution Stocks
-
Standpoint Research Initiates Coverage on McKesson (MCK) with a Buy; Best-Positioned to Benefit From Increased Demand in Generics
-
Morgan Stanley Initiates Coverage on Several Stocks in Biotechnology and Drugs Sector
-
UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
-
Lazard Capital Initiates Coverage on McKesson (MCK) with a Buy
-
Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
-
Auriga USA Initiates Coverage on McKesson (MCK) with a Hold; Attractive Entry Point for Investors with L-T View
-
CIBC Starts McKesson (MCK) at Sector Outperformer
-
JP Morgan resumes coverage on McKesson (MCK) with an Overweight
-
Citigroup Assumes Coverage on McKesson Corp (MCK) with a Hold
-
Citigroup Initiates Coverage on McKesson Corp (MCK) with a Hold
-
JMP Securities Reiterated MCK
-
Deutsche Bank Started MCK at Buy
-
CSFB Started MCK at Outperform
Back to MCK Stock Lookup
